Through our European Patient Advocacy Group (ePAG), people with lived experience and patient organisation representatives work as equal partners alongside clinicians and researchers, helping set priorities, shape decisions, and improve outcomes for people with rare and complex uro-recto-genital conditions. Their input drives our strategy, guidelines, registries, training, and research. Our ePAG is made up of patient advocates from across Europe, representing a diverse range of conditions and experiences. They: A few examples of the impact ePAG representatives have made: These examples show patients as co-creators of ERN eUROGEN’s work, not just as people consulted on it, ensuring that lived experience shapes care and research. Each year, the ePAG publishes a strategy setting out its priorities for the year ahead, alongside a report on progress against the previous year’s goals. The most recent document covers the group’s objectives for 2026, including the Rare PREPARE pre-appointment tool, patient input into guideline development for conditions such as bladder pain syndrome and penile cancer, and advocacy for the centralisation of highly specialised care, alongside a full report on what was achieved against the 2025 strategy. ➡️ Download the ERN eUROGEN ePAG Strategy 2026 and Report 2025 We warmly welcome new patient representatives. Support is available to help you get involved, including: ➡️ Download the Welcome Guide for New ERN eUROGEN ePAG Representatives Finding patient representatives in this medical field can be difficult, so new applications are warmly welcomed. Support is available through EURORDIS training, peer mentoring, and resources to help you take part in ERN activities. For questions about patient involvement, please contact the ERN eUROGEN Business Support Manager (Jen Tidman) via eurogen@uroweb.org. Independent ePAG Advocate endorsed by Orchid, the UK’s male cancer charity. Chair of the ePAG and representative for penile cancer (Workstream 3, Expertise Area 3.1). Founder and President of Associazione Italiana per le Malformazioni Anorettali (AIMAR, Italian Association for Anorectal Malformations) and active in the ARM-Net Consortium. Representative for anorectal malformations (Workstream 1, Expertise Area 1.7). Trustee of TOFS (UK) and lead for the Adult TOF Working Group. Representative for anorectal malformations (Workstream 1, Expertise Area 1.7) and adult reconstructive surgery (Workstream 2, Expertise Area 2.6). Representative of De patiëntenvereniging voor blaasextrofie Nederland (Netherlands). Representative for bladder exstrophy/epispadias (Workstream 1, Expertise Area 1.2).
European Patient Advocacy Group (ePAG)
About The ERN eUROGEN ePAG & Their Impact
Annual Strategy & Reports
Support for ePAG Participation
➡️ Download the ERN eUROGEN Rules for Patient EngagementGet Involved / Contact Us
John Osborne (Chair)

Dalia Aminoff

Kate Tyler

Miriam Wilms
Representative of SoMA e.V. (Germany), a patient organisation for anorectal malformation, Hirschsprung’s disease, and cloacal exstrophy. Representative for anorectal malformations (Workstream 1, Expertise Area 1.7).Claire Harkin
Trustee and Research Coordinator of the Klinefelter’s Syndrome Association (UK). Representative for complex genital reconstructions/DSDs (Workstream 1, Expertise Area 1.1) and male fertility (Workstream 2, Expertise Area 2.8).Lieke Janssen

Anna De Santis
Board member of Associazione Italiana Cistite Interstitiale (AICI) (Italy), supporting patients with interstitial cystitis. Represents bladder pain syndrome/interstitial cystitis (Workstream 2, Expertise Area 2.5).Robert Cornes
Orchid Male Cancer Information Nurse (UK). Representative for penile cancer and testicular cancer (Workstream 3, Expertise Areas 3.1 and 3.2).Frans Baan
Independent ePAG advocate from the Netherlands. Representative for upper tract urothelial carcinoma (Workstream 3).
